Ultrasound‐Triggered Nanobubbles for Endothelial‐Targeted Drug Delivery in the Detection and Treatment of Doxorubicin‐Induced Cardiotoxicity
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Jun Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Endothelial Cells, Drug Delivery Systems. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Chongqing Special Key Project of Technology Innovation and Application Development, China.
Abstract (Originalsprache)
Cardiotoxicity is a potential side effect of doxorubicin (DOX). However, there is a lack of effective methods for the timely detection and precise treatment of DOX‐induced cardiotoxicity (DIC). Here, snRNA‐seq of the hearts of patients with DIC and bulk RNA‐seq of DOX‐treated mice are conducted to reveal the role of endothelial dysfunction involving cell adhesion. Although previous researches have demonstrated the protective effect of dapagliflozin (DAPA) against endothelial cell (EC) injury in DIC, the low selectivity and poor accumulation greatly compromise their therapeutic efficacy. Based on these, a nanobubbles‐based DAPA nanodelivery strategy (DA/VTP‐NBs) containing a peptide targeting VCAM1, a highly expressed adhesion molecule in damaged EC, is then developed to improve DIC diagnosis and treatment. The DA/VTP‐NBs selectively recognize damaged EC in the cardiac tissues of patients with DIC and achieve pre‐functional molecular imaging. Under US‐triggered controlled release, DA/VTP‐NBs exhibit better therapeutic effects against DIC than free DAPA by amplifying the antioxidative, antiapoptotic, and proangiogenic effects. Mechanically, this therapeutic effect is attributed to the inhibition of mtDNA‐cGAS‐STING axis. The proposed DA/VTP‐NBs system presents an effective strategy for timely detection and accurate treatment of DIC, providing potential clinical benefits for DIC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, The First Affiliated Hospital (Southwest Hospital) of Army Medical University, Chongqing, China.
ORCID-Profile: Yanli Guo
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Chongqing Special Key Project of Technology Innovation and Application Development, China
- Talent Plan Program of Chongqing
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Zhang, J., Ling, Y., Li, X., Liu, D., Dong, L., Chen, X., Sun, Y., Shang, Y., & Guo, Y. (2026). Ultrasound‐Triggered Nanobubbles for Endothelial‐Targeted Drug Delivery in the Detection and Treatment of Doxorubicin‐Induced Cardiotoxicity. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505898
Vancouver
Zhang J, Ling Y, Li X, Liu D, Dong L, Chen X, et al. Ultrasound‐Triggered Nanobubbles for Endothelial‐Targeted Drug Delivery in the Detection and Treatment of Doxorubicin‐Induced Cardiotoxicity. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505898
BibTeX
@article{Zhang2026,
author = {Zhang, Jun and Ling, Yi and Li, Xin and Liu, Deng and Dong, Li and Chen, Xuemei and Sun, Yingxin and Shang, Yongning and Guo, Yanli},
title = {Ultrasound‐Triggered Nanobubbles for Endothelial‐Targeted Drug Delivery in the Detection and Treatment of Doxorubicin‐Induced Cardiotoxicity},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505898}
}
EUVIMED